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Abstract  
Protein glycosylation plays essential roles in protein structure, stability and activity such 
as cell adhesion. The cadherin superfamily of adhesion molecules carry O-linked 
mannose glycans at conserved sites and it was recently demonstrated that the TMTC1-
4 genes contribute to the addition of these O-linked mannoses. Here, biochemical, cell 
biological and organismal analysis was used to determine that TMTC3 supports the O-
mannosylation of E-cadherin, cellular adhesion and embryonic gastrulation. Using 
genetically engineered cells lacking all four TMTC genes, overexpression of TMTC3 
rescued O-linked glycosylation of E-cadherin and cell adherence. The knockdown of the 
Tmtcs in Xenopus laevis embryos caused a delay in gastrulation that was rescued by 
the addition of human TMTC3. Mutations in TMTC3 have been linked to neuronal cell 
migration diseases including Cobblestone lissencephaly. Analysis of TMTC3 mutations 
associated with Cobblestone lissencephaly found that three of the variants exhibit 
reduced stability and missence mutations were unable to complement TMTC3 rescue of 
gastrulation in Xenopus embryo development. Our study demonstrates that TMTC3 
regulates O-linked glycosylation and cadherin-mediated adherence, providing insight 
into its effect on cellular adherence and migration, as well the basis of TMTC3-
associated Cobblestone lissencephaly. 
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Introduction  
Protein glycosylation is the most common and diverse co/post-translational protein 
modification (Freeze and Elbein, 2009). Carbohydrates play general metabolic, 
structural and biophysical roles in the cell (O’Connor and Imperiali, 1996; Apweiler et 
al., 1999; Solá and Griebenow, 2009; Varki and Sharon, 2009; Price et al., 2012; Hebert 
et al., 2014). There are two general types of glycosylation that are categorized by the 
type of bond used to covalently attach the carbohydrate to the protein (Imperiali and 
Hendrickson, 1995; Jayaprakash and Surolia, 2017). N- and O-linked glycans are 
attached to proteins through N-glycosidic (Asn) or O-glycosidic (Ser/Thr) bonds, 
respectively. A third of the proteome is targeted to the secretory pathway in eukaryotic 
cells where both N- and O-linked modifications are commonly observed (Wallin and von 
Heijne, 1998; Chen et al., 2005; Choi et al., 2010). The endoplasmic reticulum (ER) 
serves as the entry portal for secretory pathway cargo. The majority of the proteins in 
the ER are modified by N-linked glycans; however, a restricted fraction is modified by O-
linked glycans (Apweiler et al., 1999; Vester-Christensen et al., 2013). 
A diverse set of O-glycans are added in the ER that include mannose, fucose, 
glucose or N-acetyl glucosamine (Joshi et al., 2018). O-mannosylation is conserved 
from fungi to mammals. It is initiated by the transfer of a mannose saccharide from a 
donor dolichol P-mannose substrate embedded in the ER membrane to a Ser/Thr on 
the target protein (Bause and Lehle, 1979). This transfer is catalyzed by ER resident 
protein O-mannosyltransferases most commonly involving POMT1 and POMT2 with -
dystroglycan as the main substrate in mammals, and Pmt1-7 in yeast (Wing et al., 1992; 
Strahl-Bolsinger et al., 1993; Immervoll et al., 1995; Lussier et al., 1995; Guerreiro et al., 
1996). Their general architecture is that of large polytopic membrane proteins, which 
display variations of a diacidic motif (i.e. Asp-Glu) in the first luminal loop region 
proximal to the membrane (Liu and Mushegian, 2003; Lairson et al., 2008; Loibl and 
Strahl, 2013; Bai et al., 2019)(Supplemental Fig. 1B). Metazoan and yeast O-
mannosyltransferases also contain conserved mannosyltransferase, inositol 
triphosphate and ryanodine receptor (MIR) domains. MIR domains have been shown to 
be essential for enzymatic activity in yeast and have been implicated in substrate 
binding based on studies performed on other mammalian MIR domain containing 
proteins such as SDF2 (Girrbach et al., 2000; Ponting, 2000; Meunier et al., 2002; 
Lommel et al., 2011; Fujimori et al., 2017).  
A new putative family of O-mannosyltransferases was recently discovered in 
mammals (Larsen et al., 2017a, 2017b). This family is comprised of four 
tetratricopeptide repeat (TPR)-containing proteins that appear to be ER polytopic 
transmembrane proteins called TMTC1-4 (transmembrane and TPR-containing proteins 
1-4)(Della-Morte et al., 2011; Racapé et al., 2011; Cao et al., 2012; Sunryd et al., 2014; 
Larsen et al., 2017a; Li et al., 2018). TMTC1, 2 and 4 are ER proteins involved in Ca2+ 
regulation as they associate with ER Ca2+ re-uptake pump SERCA2B (Sunryd et al., 
2014; Li et al., 2018). The knockouts of TMTC1-4 have been shown using 
glycoproteomics to be involved in the O-mannosylation of cadherins (Larsen et al., 
2017a, 2019). TMTC1-4 contain homologous structural elements as their N-terminal 
halves are comprised of a number of hydrophobic domains and the C-terminal halves 
are predicted to be composed mainly of long stretches of TPR motifs (8-12) 
(Karpenahalli et al., 2007; Letunic and Bork, 2018)(Fig. 1A). Two of the TMTCs, TMTC3 
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and TMTC4, contain putative diacidic motifs (Asp-Asp or Glu-Glu) on N-terminal luminal 
loops based on predictive topology, making them appear homologous to the POMTs 
and Pmts (Hessa et al., 2007; Bai et al., 2019)(Supplemental Fig. 1B and C).  
TPRs are protein structural motifs that support protein-protein interactions and 
are frequently found on co-chaperones (Magliery and Regan, 2005; Brehme et al., 
2014). A single TPR motif consists of a degenerate 34-amino acid sequence that is 
comprised of two anti-parallel -helices (D’Andrea and Regan, 2003; Magliery and 
Regan, 2005). TPR domains are most commonly found in a cluster of three TPR motifs; 
however, clusters comprised of up to sixteen sequential TPRs have been observed 
(D’Andrea and Regan, 2003). Proteins with three TPRs in a cluster favor the recognition 
of short and defined sequences, whereas proteins with long stretches of consecutive 
TPRs tend to be more promiscuous in their selectivity. Unlike classic TPR co-
chaperones, which contain three to four consecutive motifs, the composition of TMTC1-
4, with eight to twelve consecutive motifs, is similar to that of the well-studied TPR-
containing cytoplasmic O-GlcNAc transferase (OGT), which contains a stretch of 12.5 
TPRs followed by a C-terminal catalytic domain (Jínek et al., 2004; Lazarus et al., 
2011). The structure of OGT reveals that the TPRs form a super helix responsible for 
homodimerization of OGT and are proposed to scaffold interactions with other proteins, 
potentially playing a role in substrate selectivity. Dimerization of the TPR domain is 
mediated by the convex faces of the superhelical monomers, and the concave surface 
contains conserved Asn, which form a continuous ladder. This Asn conservation is 
similarly observed in the ARM-repeat proteins importin- and -catenin (Conti et al., 
1998; Huber and Weis, 2001). The Asn in these proteins contribute to binding of a 
target peptide (nuclear localization sequence with importin- and E-cadherin with  -
catenin), suggesting that the TMTCs may use a similar mechanism of protein-protein 
interaction and substrate selection.  
Mutations in the TMTC genes have been linked to various human disease states 
(Jerber et al., 2016; Runge et al., 2016; Farhan et al., 2017; Li et al., 2018). Point 
mutations in human TMTC2 and the knockout of Tmtc4 in mice result in hearing loss 
(Runge et al., 2016; Guillen‐ Ahlers et al., 2018; Li et al., 2018). Ten mutations in 
TMTC3 are associated with neuronal cell migration diseases (Jerber et al., 2016; 
Farhan et al., 2017). Homozygous and compound heterozygous mutations resulting in 
single amino acid or frame shift changes in TMTC3 were identified in a cohort of 
families with recessive forms of Cobblestone lissencephaly, a severe brain malformation 
in which over migration of neurons and glial cells results in the formation of cortical 
dysplasia or brain development abnormalities (Jerber et al., 2016). Another study 
identified heterozygous variants of TMTC3 in patients with periventricular nodular 
heterotopia (PVNH), a common brain malformation caused by the failure of neurons to 
migrate from the ventricular zone to the cortex (Farhan et al., 2017). While mutation or 
loss of the TMTC genes has been associated with a number of diseases, an 
understanding of how these mutations result in specific defects is unclear. 
Here, in silico, biochemical, cell and developmental biological approaches were 
used to expand our understanding of the organization, localization, activity and function 
of TMTC3 and TMTC4. Previously uncharacterized TMTC3 and 4 were identified as ER 
TPR-containing membrane proteins with their TPR domains orientated within the ER 
lumen. Using TMTC HEK293 knockout cells, it was demonstrated that TMTC3 
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complementation recovered the O-mannosylation of E-cadherin. While the knockout of 
the TMTCs did not affect the stability, localization or trafficking of E-cadherin, it did 
affect cellular adherence and the overexpression of TMTC3 was able to partially recover 
adherence, specifically E-cadherin mediated adherence. Subsequent analysis of protein 
O-mannosyltransferase protein architecture showed that TMTC3 shares functional 
similarity with O-mannosyltransferases (POMT1/2 and Pmt1-7) as it contains two 
diacidic motifs (Asp-Asp and Glu-Glu) located in a putative N-terminal luminal loop and 
mutation of the Asp-Asp motif results in reduced TMTC3 stability. Additionally, the 
knockdown of Tmtc3 and Tmtc4 in Xenopus laevis resulted in an embryonic gastrulation 
delay phenotype and the delay was rescued by human TMTC3. There are eight disease 
variants of TMTC3 recently associated with Cobblestone lissencephaly and two 
associated with PVNH (Jerber et al., 2016; Farhan et al., 2017). While novel 
biochemical characterization of eight of these disease variants showed that they all 
localize to the ER, three of them are less stable than wild type (WT) and none of the 
missense mutations are able to rescue the delay in gastrulation caused by the 
knockdown of Tmtc3 in Xenopus laevis. The identification of TMTC3’s role in O-
glycosylation of E-cadherin in combination with its knockdown in Xenopus embryos 
provides further insight into the role O-glycosylation plays in cell-cell adhesion and 
migration, and the etiology of Cobblestone lissencephaly caused by TMTC3 mutation. 
 
Results 
 
TMTC3 and TMTC4 are ER resident proteins. In silico analysis, using SignalP4.0, 
TargetP1.1, ΔG, TPRPred and domain architecture database SMART7, indicated that 
TMTC3 (NCBI Accession # NP_861448.2. 
(http://www.ncbi.nlm.nih.gov/protein/NP_861448.2)) and TMTC4 (NCBI Accession # 
NP_001073137.1 (http://www.ncbi.nlm.nih.gov/protein/NP_001073137)) contained a 
potential N-terminal signal sequence, ten and twelve hydrophobic segments and eleven 
and eight C-terminal TPR motifs, respectively (Fig. 1A)(Nielsen et al., 1997; 
Emanuelsson et al., 2000; Hessa et al., 2007; Karpenahalli et al., 2007; Nielsen, 2017; 
Letunic and Bork, 2018; UniProt: a worldwide hub of protein knowledge, 2019). TMTC3 
and TMTC4 cDNAs were subcloned into mammalian expression vectors encoding a C-
terminal S-tag, and their cellular localization was determined by glycosylation assay and 
confocal immunofluorescence microscopy. Secretory proteins are commonly modified in 
the ER with N-linked glycans at the consensus site Asn-Xxx-Ser/Thr. TMTC3 and 
TMTC4 possess five and three predicted N-linked glycosylation consensus sites, 
respectively (Fig. 1A), therefore a glycosylation assay was used to further analyze ER 
targeting and localization (Gupta, 2002). As the molecular weight of an N-linked glycan 
is ~2.5 kDa, the removal of N-linked glycans by glycosidase treatment results in a 
corresponding increase in mobility for the deglycosylated protein. Endoglycosidase H 
(Endo H) trims the high mannose glycans encountered in the ER while Peptide-N-
Glycosidase F (PNGase F) removes complex glycans acquired in the Golgi in addition 
to high mannose glycans.  
HEK293T cells were transfected with TMTC3 or TMTC4 containing C-terminal S-
tags. Cell lysate and media fractions were affinity precipitated with S-protein agarose 
beads followed by glycosidase treatment. Shifts upon PNGaseF treatment (Fig. 1B, 
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lanes 9 and 15) were observed for both TMTC3 and TMTC4 demonstrating that both 
proteins were targeted to the ER and received N-linked glycans. A similar increase in 
mobility was observed upon Endo H treatment (Fig. 1B, lanes 8 and 14) indicating that 
the carbohydrates were high mannose glycoforms suggesting that TMTC3 and TMTC4 
are ER resident proteins (Fig. 1B).  
COS7 cells were transfected with either TMTC3 S-tag or TMTC4 S-tag as COS7 
cells are highly amenable to imaging. Fluorescence staining of TMTC3 and TMTC4 was 
compared against an ER (ERp57) or Golgi (GM130) marker (Fig. 1C). Both TMTC3 and 
TMTC4 co-localized with ERp57, while co-localization was not observed with GM130 
(Fig. 1C). Therefore, the glycosylation profiles for TMTC3 and TMTC4 and the cellular 
distribution are consistent with TMTC3 and TMTC4 residing in the ER.  
 
TMTC3 and TMTC4 are ER membrane proteins with luminal orientated TPR 
motifs. Analysis of the TMTC3 and TMTC4 protein sequences with ΔG prediction 
demonstrated that they contained ten and twelve hydrophobic segments, respectively, 
that could potentially serve as transmembrane domains to create polytopic membrane 
proteins (Fig. 1A) (Hessa et al., 2007). Alkaline extraction of membrane fractions was 
performed to separate membrane and soluble forms of proteins following centrifugation 
to determine if TMTC3 and TMTC4 are integral membrane proteins (Mostov et al., 
1981).  
HEK293T cells were transfected with either TMTC3 or TMTC4 S-tag, and 
proteins were radiolabeled with [35S]-Met/Cys for 1 hr. Cells were homogenized in 
isotonic buffer and fractions were separated by centrifugations. TMTC3 and TMTC4 
were found in the nuclear (N) and total membrane (TM) fractions (Fig. 2A, lanes 2 and 
4). The nuclear localization of TMTC3 and TMTC4 is likely explained by the contiguous 
nature of the ER and nuclear membrane prohibiting their separation as the ER proteins 
calnexin and calreticulin were also in the nuclear fractions. Alkaline extraction of the 
total membrane fractions followed by centrifugation found TMTC3 and TMTC4 
exclusively in the membrane pellet (P) (Fig. 2A, lane 6). This profile was observed for 
the ER membrane protein, calnexin, and not its soluble paralogue calreticulin, which 
largely accumulated in the supernatant (S) (Fig. 2A, lane 5). Therefore, both TMTC3 
and TMTC4 are integral membrane proteins.  
Since TMTC3 and TMTC4 are membrane proteins, a trypsin protection assay 
was employed to determine if their C-terminal TPR motifs are positioned in the ER 
lumen or the cytoplasm. HEK293T cells were transfected with either TMTC3 or TMTC4 
constructs containing C-terminal S-tags, and cells were homogenized prior to isolation 
of ER-enriched microsomes. Isolated microsomes were resuspended in an isotonic 
buffer, and aliquots were treated with triton X-100 and trypsin as indicated. Trypsin 
treatment produced a discrete TMTC3 fragment of ~83.5 kDa and TMTC4 fragments of 
~67.8 and 57.1 kDa (Fig. 2B, compare lanes 5 to 6 and 9 to 10). As the TPR domains 
and S-tags are both at the C-termini, this demonstrated that the TPR domains of 
TMTC3 and TMTC4 were positioned in the ER lumen (Fig. 2C). Combined with the 
modification of the glycosylation sites added to the TPR rich regions (Fig. 1B), these 
results demonstrated that the TPR motifs for both of the membrane proteins, TMTC3 
and TMTC4, were facing the ER lumen. 
 
 6 
Characterization of TMTC3 and TMTC4 transcripts was performed to compare 
TMTC3 and 4 to known O-mannosyltransferases. Both the basal mRNA levels of the 
two classes of proteins were examined, as well as whether the TMTC3 and TMTC4 
genes are transcriptionally regulated by ER stress as proteins that reside in the 
secretory pathway are frequently transcriptionally upregulated by stress (Walter and 
Ron, 2011). TMTC1-4 and POMT1/2 mRNAs were similarly expressed with TMTC4 and 
POMT1 showing the highest levels at ~2.5% of the reference gene -actin 
(Supplemental Fig. 2A). All TMTCs and POMTs were significantly less expressed than 
the ER resident chaperone, BiP, which is ~20% of -actin (Supplemental Fig. 2A).  
To determine whether the TMTC3 and TMTC4 genes are transcriptionally 
regulated by ER stress, HEK293A cells were exposed to different ER stress conditions. 
Cells were subjected to N-glycan synthesis inhibition (tunicamycin), calcium depletion 
(thapsigargin), redox stress (dithiotreitol, DTT), inhibition of anterograde protein 
trafficking (brefeldin A) or proteasomal inhibition (MG132). RNA was harvested from 
cells followed by reverse transcription to generate cDNA and changes in gene 
expression were measured by qRT-PCR. TMTC3 gene expression was increased with 
thapsigargin and brefeldin A treatment by ~2.1 and 2.5-fold, respectively (Supplemental 
Fig. 2B). TMTC4 gene expression was increased with tunicamycin treatment by 1.8-fold 
and 1.5-fold with brefeldin A treatment (Supplemental Fig. 2B). Thapsigargin, DTT and 
MG132 did not produce a significant increase in gene expression of TMTC3, although 
the transcription of BiP was stimulated by all treatments. Out of the TMTCs, TMTC4 
was up-regulated by stress most significantly and POMT1 exhibited similar up-
regulation in response to stress, which may correspond to their basal mRNA levels 
being higher or UPR induction upon their respective deletion (Jonikas et al., 2009; Li et 
al., 2018). 
 
TMTC3 rescues O-mannosylation of E-cadherin 
TMTC1, TMTC2 and TMTC4 have been shown to associate with SERCA2B and play a 
role in calcium regulation (Sunryd et al., 2014; Li et al., 2018). To investigate the cellular 
role of TMTC3, initially its binding to SERCA2B was tested. HEK293T cells were 
transfected with either TMTC1, TMTC2, TMTC3 or TMTC4 cDNA. Upon cell 
homogenization and total membrane isolation, the TMTCs were affinity purified, and 
associated proteins were resolved by SDS-PAGE. Binding to SERCA2B was monitored 
by immunoblotting (Fig. 3A). As previously shown, TMTC1, TMTC2 and TMTC4 
associated with SERCA2B; however, no interaction between TMTC3 and SERCA2B 
was observed (Fig. 3A, lane 9). Therefore, unlike the other TMTCs, TMTC3 does not 
appear to associate with SERCA2B. 
 TMTC1-4 were discovered to contribute to the O-mannosylation proteome when 
a subset of substrates remained O-mannosylated in cells that lacked the known O-
mannosyltransferases, POMT1 and POMT2 (Larsen et al., 2017a, 2017b). A significant 
difference in O-mannosylation of the cadherin family of proteins was observed upon 
knockout of all four TMTCs in HEK293 cells (HEK293SC/TMTC1,2,3,4) (Larsen et al., 
2017a). Glycoproteomics was used to determine that E-cadherin was O-mannosylated 
at nine sites (Supplemental Fig. 1A). These results were obtained using HEK293 cells 
also lacking COSMC and POMGnT1 termed ―SimpleCell" or HEK293SC cells. COSMC 
is an essential chaperone to T-synthase that modifies glycoproteins with an O-GalNAc 
 7 
linked saccharide, and POMGnT1 is a glycosyltransferase that appends 1,2-GlcNAc to 
O-mannose in the Golgi (Yoshida et al., 2001; Wang et al., 2010). The use of HEK293SC 
cells created truncated, more homogenous O-mannosylated modifications amenable for 
glycomics analysis (Vester-Christensen et al., 2013).    
 To assess potential O-mannosyltransferase activity of the individual TMTCs, a 
glycosylation and carbohydrate binding assay was employed in glycosyltransferase 
deficient cell lines including  HEK293SC/TMTC1,2,3,4 cells with TMTCs complementation 
(Fig. 3B). These cells were transfected at similar levels individually with S-tagged 
TMTC1, 2, 3 or 4 (Supplemental Fig. 3A). Cell lysates were collected and divided into 
two fractions. One fraction of the lysate was treated with PNGaseF to remove N-linked 
glycans (Fig. 3B, lane 2) prior to both fractions being affinity purified using the lectin, 
concanavalin A (Con A). Samples were analyzed via SDS-PAGE and immunoblotted 
with E-cadherin antisera. 
 E-cadherin levels were not affected by the deletion of COSMC or the 
glycosyltransferases (Supplemental Fig. 4A). E-cadherin appears to receive O-linked 
glycans as it was pulled down by Con A even though the glycoproteins lacked N-linked 
glycans in the PNGaseF treated sample (Fig. 3B, top blot, lane 2). Subsequently, the 
same assay was performed in HEK293SC/POMT1,2 cells and O-glycosylated E-cadherin 
still bound to Con A (Fig. 4B, lane 2, middle blot). However, in HEK293SC/TMTC1,2,3,4  
cells, O-glycosylated E-cadherin was not recovered by Con A after N-linked glycan 
removal suggesting a significant loss of both N- and O-linked glycans (Fig. 3B, lane 2, 
bottom blot). This result was similarly observed in HEK293SC/TMTC1,2,3,4 cells transfected 
with S-tagged TMTC1, 2 or 4 (Fig. 3B, lanes 4, 6 and 10, bottom blot). However, cells 
transfected with TMTC3 were able to recover Con A-bound O-linked glycosylated E-
cadherin (Fig. 3B, lane 8, bottom blot). The recovery of O-glycosylated E-cadherin by 
TMTC3 expression was repeated and quantified to confirm that TMTC3 contributed to 
the O-linked glycosylation of E-cadherin (Fig. 3C).  
To determine whether TMTC3 mediated O-linked glycosylation of E-cadherin 
included O-mannosylation, a combinatorial endoglycosidase assay was performed. S-
tagged TMTC3 was transfected into HEK293SC/TMTC1,2,3,4 cells and the lysate was 
subsequently treated with PNGaseF or both PNGaseF and 1-2,3,6 mannosidase prior 
to affinity purification with Con A, as the mannosidase would specifically remove 
mannose residues. O-glycosylated E-cadherin was recovered from cells complemented 
with TMTC3 after PNGaseF treatment; however, the amount bound to Con A upon 
subsequent 1-2,3,6 mannosidase treatment was reduced by ~45%, indicating that 
TMTC3 contributes to O-mannosylation of E-cadherin (Fig. 3D insert, compare lanes 3 
to 2).  
 
TMTC3 enhances cellular adherence and binding to E-cadherin. Studies on protein 
O-mannosylation in yeast have revealed that O-glycans are important for protein 
stability, trafficking, localization, function and stress response (Yang et al., 2009; 
Petkova et al., 2012; Xu and Ng, 2015). To understand the effect of TMTC3 on E-
cadherin, the expression, stability and trafficking of E-cadherin was assessed in 
TMTC1-4 knockout cells. Briefly, HEK293SC, HEK293SC/POMT1,2 and HEK293SC/TMTC1,2,3,4 
cells were lysed and subjected to lectin affinity purification with Con A prior to samples 
being analyzed via SDS-PAGE and immunoblotted with E-cadherin antisera. There was 
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no significant difference observed in expression between cell types (Supplemental Fig. 
4A). Cellular trafficking was also assessed by endoglycosidase sensitivity in 
combination with cycloheximide chase and a significant difference was not observed 
(data not shown). Cell surface localization of several cadherins, including E-cadherin, 
was monitored using confocal immunofluorescence microscopy. HEK293SC, 
HEK293SC/POMT1,2 and HEK293SC/TMTC1,2,3,4  cells were fixed and stained for pan-cadherin 
(Fig. 4A). In all three cell lines, cadherins localized to the cell surface. Interestingly, a 
morphology defect was observed in cells lacking TMTC1-4. While cell surface staining 
in HEK293SC and HEK293SC/POMT1,2 cells appeared round and evenly distributed, 
cadherin staining in HEK293SC/TMTC1,2,3,4  cells showed irregularity.  
Cell-cell adhesion interactions are essential for embryogenesis, tissue 
morphogenesis and renewal (Halbleib and Nelson, 2006). Adherins junctions are the 
sites of cell-cell contact where adhesion is mediated by cell-surface receptors of the 
cadherin family (Meng and Takeichi, 2009). E-cadherin plays a critical role in cell-cell 
adhesion and development and O-mannosylation has been shown to be important for 
its role in forming adherins junctions (Lommel et al., 2013). To determine the effect of 
TMTCs on E-cadherin mediated cellular adherence, general cellular adherence was 
evaluated. HEK293SC, HEK293SC/POMT1,2 and HEK293SC/TMTC1,2,3,4 cells were re-
suspended in growth media and subsequently plated and allowed to adhere for 30 min. 
After 30 min, the floating cells were collected for each cell type and adhered cells were 
trypsinized and collected. Each fraction was quantified and the percent of floating cells 
over the total was calculated. HEK293SC and HEK293SC/POMT1,2 cells showed similar 
levels of adherence with average floating cell percentages at ~23% (Fig. 4B). 
Contrastingly, HEK293SC/TMTC1,2,3,4 cells demonstrated reduced cellular adherence as 
the percentage of floating cells observed was ~33% (Fig. 4B). To determine if any one 
of the TMTCs individually contributed to cellular adherence TMTC1, 2, 3 and 4 cDNA 
was transfected into HEK293SC/TMTC1,2,3,4 cells. The adherence assay described above 
was performed and the percentage of adhered cells as compared to mock was 
calculated. Upon establishing a baseline using the mock treated cells, TMTC3 
transfected cells were able to recover adherence the most with an observed increase 
over mock of ~9% (Fig. 4C).  
Cadherins are cell-surface membrane glycoproteins that contain multiple repeats 
of extracellular cadherin domains and they mediate cell-cell adhesion by trans 
homodimerization between apposed cells (Cavallaro and Christofori, 2004; Yagi, 2008; 
Brasch et al., 2012). E-cadherin mediated cell-cell adhesion was assessed in 
HEK293SC, HEK293SC/POMT1,2 and HEK293SC/TMTC1,2,3,4 cells to determine if genetic 
manipulation of the glycosyltransferases affected its adhesion function. Purified 
extracellular domain of E-cadherin was incubated overnight to allow for attachment to 
the plate surface. HEK293SC, HEK293SC/POMT1,2 and HEK293SC/TMTC1,2,3,4 cells were then 
resuspended and ~60,000 cells were seeded on the purified substrate. Cells were 
allowed to adhere for 1 hr prior to discarding unadhered cells. Adhered cells were then 
fixed with paraformaldehyde before permeabilization with triton X-100, and nuclei were 
stained with Hoescht. Hoescht images were captured at five different locations within 
each well and the number of nuclei quantified. HEK293SC/TMTC1,2,3,4 cells showed 
markedly reduced binding to the extracellular region of E-cadherin compared to 
HEK293SC and HEK293SC/POMT1,2 cells (Fig. 4D and E). The same assay was performed 
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on HEK293SC/TMTC1,2,3,4 cells expressing TMTC3 and E-cadherin mediated adherence 
was recovered. These results, combined with the results from the carbohydrate binding 
assay (Fig. 3B and C), suggest that TMTC3 affects E-cadherin mediated adherence 
through O-mannosylation of the glycoprotein. 
 
TMTC3 disease variants exhibit reduced stability. Cell-cell adhesion interactions are 
essential for embryogenesis, tissue morphogenesis and renewal, all key processes of 
development (Halbleib and Nelson, 2006). Cobblestone lissencephaly is a severe brain 
malformation characterized by irregular borders, dysplasia, hypoplasia and 
dysmyelination, which are due to overmigration of neurons and glial cells beyond the 
external basement membrane. The cause of this over migration defect is impaired 
interactions between glial limitans and the extracellular matrix of the basement 
membrane (Siegenthaler and Pleasure, 2011; Barkovich et al., 2012). Glycosylated cell 
surface binding receptors provide a physical link between the cytoskeleton of the glial 
cells and the basement membrane (Barresi and Campbell, 2006). Loss of glycosylation 
of these molecules contributes to functional defects during development by reducing 
binding to the extracellular matrix (Michele et al., 2002). Cobblestone lissencephaly has 
been associated with mutations in sixteen genes, and twelve of these genes are 
involved in O-linked glycosylation, including POMT1 and 2 (Jerber et al., 2016).  
Recently, a study identified biallelic mutations in TMTC3 from Cobblestone 
lissencephaly patients exhibiting intellectual disability, hypotonia and delayed 
milestones (Jerber et al., 2016). Six families had a total of eight distinct mutations in 
affected individuals, four of which were homozygous and two were compound 
heterozygous. Using predictive algorithms, the altered organization of seven of these 
mutants and a compound heterozygous mutant (R71H) associated with another 
neuronal disorder (PVNH) was analyzed (Supplemental Fig. 5A). The point mutations 
do not appear to alter organization; however, the resulting residue mutations change the 
charge of the native residue, which may have some topological or functional effect on 
TMTC3 as some of these mutations are in close proximity to the putative active sites 
(Supplemental Fig. 5A, H67D, R71H and G384E). The frame shift mutations beginning 
at residue positions 488, 562 and 654 greatly change the number and organization of 
the predicted TPR motifs resulting in truncated forms of TMTC3. Additionally, these 
frameshift mutations could result in five to seven non-native amino acids being 
transcribed before the premature stop codon. The frameshift mutation at position 841 
results in a shortened C-terminus and three putative non-native residues, and the early 
stop codon mutation at position 873 would result in a protein that is missing 41 amino 
acids. 
TMTC3 disease variants were characterized for ER localization via glycosidase 
assay and immunofluorescence confocal microscopy. TMTC3 disease variant 
constructs, engineered to harbor any resulting non-native residues and C-terminal S-
tags, were transfected into HEK293T cells prior to cell lysate and media fractions being 
affinity purified with S-protein agarose beads followed by glycosidase treatment. Shifts 
upon PNGaseF treatment (Supplemental Fig. 5B, lanes 3 and 9) were observed for all 
constructs indicating that these proteins were targeted to the ER and received N-linked 
glycans. A similar increase in mobility was observed upon Endo H treatment indicating 
that the carbohydrates were high mannose glycoforms (Supplemental Fig. 5B, lanes 2 
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and 8). All TMTC3 disease variants co-localized with calreticulin (CRT), while co-
localization was not observed with the Golgi marker, GM130, when 
immunofluorescence staining was performed in transfected COS7 cells (Supplemental 
Fig. 6). Therefore, the glycosylation profiles and the cellular distribution are consistent 
with TMTC3 disease variants residing in the ER like wild type (WT) TMTC3.  
The only exception to ER localization studies was the frameshift mutation 
R488Efs. This mutant did not express in COS7 cells so cellular localization via 
immunofluorescence was unable to be determined. In order to assess expression of 
R488Efs S-tag, MG132, a proteasome inhibitor, was added to the media of cultured 
cells transfected with the S-tagged mutant construct. The immunoblot revealed that 
R488Efs was stabilized by proteasome inhibition suggesting that once translated, it is 
quickly degraded (Fig. 5C, compare lane 3 to 4). Additionally, a glycosylation profile was 
obtained using proteasome inhibition (Supplemental Fig. 5B, top right panel). A shift 
upon EndoH and PNGaseF treatment was not observed, therefore this mutant may not 
be glycosylated. This could be explained by the predictive organizational outcome of 
this variant as the frameshift results in a severe truncation of the protein, including most 
of the predicted N-linked glycosylation sites (Supplemental Fig. 5A). 
The rapid degradation of the R488Efs variant suggested that instability of TMTC3 
could lead to disease, therefore the stability of the remaining disease variants was 
analyzed. HEK293T cells were transfected with the S-tagged TMTC3 mutant constructs 
and cells were treated with cycloheximide for 0-24 hr. Cells were collected at the 
indicated time points, lysed and subjected to S-protein affinity purification (Fig. 5A). WT 
TMTC3 has a half-life of ~12 hr (Fig. 5B, black line). Several of the mutants show similar 
or slightly extended half-lives; however, F562Lfs and G384E mutations lead to 
significantly reduced half-lives of ~8 and 2 hr, respectively (Fig. 5B, light blue and purple 
lines). This increased instability could explain a disease phenotype. Three of the 
disease variants are rapidly recognized as non-native and degraded. Further 
biochemical investigation is necessary to better understand the effects of such 
mutations. 
 
TMTC3 and TMTC4 knockdown delays gastrulation in Xenopus laevis. Tissue 
morphogenesis during development is dependent upon the cadherin family of cell-cell 
adhesion molecules, which includes classical cadherins, protocadherins and atypical 
cadherins (Halbleib and Nelson, 2006). During vertebrate morphogenesis, the various 
cadherin family members are differentially expressed in a variety of tissues (Nandadasa 
et al., 2009). E-cadherin has been shown to play a central role in cell-cell adhesion 
during embryo development before implantation. If O-mannosylation is prevented either 
genetically or biochemically, embryo development is arrested (Lommel et al., 2013). 
Staining for E-cadherin during mouse embryonic development showed that it is retained 
basolaterally, however, it was reduced at sites that also showed reduced adherence. 
Analysis of the TMTCs protein sequence conservation among commonly studied 
species revealed strong similarity to the Tmtc paralogues in Xenopus laevis, therefore 
the potential phenotypic effects of Tmtc knockdown in developing Xenopus embryos 
was assessed (Supplemental Fig. 7A). In Xenopus, C-cadherin is the major cadherin 
expressed maternally persisting during early cell division and gastrulation. During 
gastrulation, E-cadherin is expressed in the ectoderm. At the end of gastrulation, the 
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ectoderm becomes segregated into the dorsal neural ectoderm, which then activates 
expression of N-cadherin and turns off E-cadherin. The non-neural ectoderm retains E-
cadherin expression becoming the epidermis (Nandadasa et al., 2009). A global mRNA 
expression study conducted in developing Xenopus embryos showed that tmtc3 and 
tmtc4 mRNA are maternally expressed and that tmtc3 is strongly expressed during the 
mid-blastula transition (MBT) and remains abundant throughout gastrulation (Session et 
al., 2016)(Supplemental Fig. 7B). As both e-cadherin and tmtc3 and tmtc4 mRNA begin 
to increase in expression prior to gastrulation phase, the effect of Tmtc knockdown was 
observed during gastrulation. 
Morpholino sequences (Genetools LLC) were designed to match the ATG region 
of Xenopus laevis Tmtc1 to 4 to block protein translation of both allo allele (L and S). 
Individual morpholinos were microinjected into embryos at the 1-cell stage to ensure 
that every cell contained morpholino upon subsequent divisions. The injected embryos 
were allowed to develop as normal and gastrulation was observed via time-lapse video 
microscopy using an inverted light microscope. The diameter of the blastopore was 
measured during gastrulation (stage 10-12) for all injected embryos as well as non-
injected controls. Those injected with the Tmtc1, 2, 3 or 4 morpholino showed a 
significant delay in gastrulation as exhibited by a larger blastopore diameter than non-
injected controls at the same time point (Fig. 6A and B). The most significant effect was 
observed for Tmtc3 and Tmtc4 morpholino injected embryos. With tmtc3 mRNA 
showing the highest expression in development (Supplemental Fig. 7B) and to confirm 
specificity of this delay in gastrulation, human WT TMTC3 mRNA was subsequently 
injected after the Tmtc3 morpholino in 1-cell stage embryos and gastrulation was 
observed as previously described (Fig. 6A and B). Human WT TMTC3 was able to 
completely rescue the delay in gastrulation caused by knocking down Xenopus Tmtc3, 
suggesting that the developmental defect is specific to TMTC3 and that the human and 
Xenopus proteins share similar functions.  
The O-mannosyltransferases POMT1/2 and Pmt1-7 contain diacidic motifs 
positioned near the membrane in the lumen of the ER, which are hypothesized to serve 
as the active site for the transferase activity (Supplemental Fig. 1B) (Lommel et al., 
2011; Bai et al., 2019). TMTC3 has two N-terminal diacidic motifs that are proposed to 
be luminally orientated, Asp31Asp32 (DD) and Glu63Glu64 (EE). (Supplemental Fig. 
1C). To determine whether a putative active site could be assigned to TMTC3, the 
diacidic motifs were mutated to di-Ala motifs. The TMTC3 DD>AA and EE>AA 
constructs were injected at the 1-cell stage with Tmtc3 morpholino. While injected 
embryos were observed for gastrulation, a number of embryos were also collected to 
assess construct expression. Briefly, embryos were homogenized in lysis buffer prior to 
total protein precipitation with trichloroacetic acid and analysis by SDS-PAGE and 
immunoblotting for S-tag epitope (Supplemental Fig. 7C). The analysis showed that all 
constructs, human WT TMTC3, DD>AA and EE>AA were similarly expressed. While the 
WT TMTC3 was able to rescue the gastrulation defect, neither the DD>AA nor EE>AA 
construct could (Fig. 6A and B). Given that a simple point mutation in TMTC3 (G384E) 
resulted in significantly decreased stability of the protein (Fig. 5A and B), it is possible 
that mutating the two negatively charged residues within the first luminal loop of TMTC3 
to neutral Ala could affect function of TMTC3.  
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Mutations in TMTC3 have been identified in patients with diseases resulting from 
defects in cell migration. Since the process of gastrulation in metazoans is dependent 
upon a series of complex and coordinated cell movements, TMTC3 disease variants 
were assessed in the previously described Xenopus gastrulation assay (DeSimone et 
al., 2007; Winklbauer, 2012). One-cell stage embryos injected with Tmtc3 morpholino 
were subsequently injected with human TMTC3 mRNA harboring three of the point 
mutations found in patients, H67D, R71H and G384E (Supplemental Fig. 5A). The 
embryos were allowed to develop to gastrulation prior to being assessed as previously 
described. Tmtc3 morpholino injected embryos display an average increased blastopore 
diameter of ~880 m compared to non-injected or WT TMTC3 rescue controls, ~530 
and ~600 m, respectively (Fig. 6). TMTC3 disease mutants H67D, R71H and G384E 
possessed increased blastopore diameters of ~1100, ~1000 and ~930 m, respectively. 
This data shows that while WT TMTC3 rescues the gastrulation defect, the disease 
variants resulting in point mutations in TMTC3 increased developmental delays 
suggesting that they may act as dominant negative mutants.  
 
Discussion 
Our study demonstrates that TMTC3 contributes to the O-mannosylation of E-cadherin 
and this modification is important for E-cadherin mediated cell-cell adhesion. TMTC3 is 
an integral ER membrane protein, likely adopting a polytopic structure, with its putative 
TPR region residing within the ER lumen. The knockdown of Tmtc3 in Xenopus laevis 
led to a delay in embryonic gastrulation, a process that is heavily dependent on cell-cell 
adhesion and migration (Winklbauer, 2012). Although the TMTCs all share similar 
protein domain architecture and the TMTC mRNA profiles is comparable to previously 
known O-mannosyltransferases, POMT1 and 2, TMTC3 appears to play a critical role in 
cell adhesion. This study provides insight into cell migration diseases caused by 
mutations in TMTC3.  
TMTC3 shares 24-28% identity and 38-43% similarity in amino acid sequence 
with the other members of the TMTC protein family, suggestive of a common 
evolutionary origin (Sievers et al., 2014). TMTC3 and TMTC4 are present in the 
chordata phylum and recent analysis shows that they are conserved in protists (Larsen 
et al., 2019). Like TMTC1 and TMTC2, TMTC3 and TMTC4 are divided into two regions 
that appear to create distinct domains, an N-terminal hydrophobic region and a C-
terminal domain consisting of large TPR clusters (Sunryd et al., 2014). G predicts that 
TMTC3 and TMTC4 have ten and twelve potential transmembrane domains, 
respectively (Fig. 1A). Alkaline extraction of total membrane preparations demonstrated 
that TMTC3 and TMTC4 are integral membrane proteins and trypsin digestion of these 
preparations produced partially protected C-terminal fragments of both TMTC3 and 
TMTC4 that correspond to the entire predicted C-terminal TPR region, as well as a 
number of the hydrophobic segments. Therefore, TMTC3 and TMTC4 appear to be 
polytopic membrane proteins with their hydrophobic N-termini providing long stretches 
of multiple hydrophobic segments and exposed cytoplasmic loops.  
Protein O-mannosylation involves the transfer of a mannose from an activated 
dolichol monophosphate mannose to the hydroxyl group on a Ser or Thr. The O-
mannosyltransferase activity for yeast Pmts appears to involve a diacidic motif (Asp-
Glu) that resides near the membrane in luminal loop 1 of the polytopic proteins (Lommel 
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et al., 2011; Bai et al., 2019)(Supplemental Fig. 1B). TMTC3 possesses two diacidic 
motifs in the first predicted luminal loop (Asp31Asp32 (DD) and Glu63Glu64 (EE)). 
These diacidic residues were mutated to Ala and the stability of TMTC3 was monitored 
(Supplemental Fig. 3B, lower panel). While TMTC3EE>AA was expressed at similar levels 
to WT TMTC3, TMTC3DD>AA was not visualized after transfection. To determine if 
TMTC3DD>AA was unstable, a cycloheximide chase was carried out for WT TMTC3, 
TMTC3DD>AA, and TMTC3EE>AA (Supplemental Fig. 3C). TMTC3DD>AA was turned over 
rapidly when compared to WT TMTC3 and TMTC3EE>AA indicating that TMTC3DD>AA was 
unstable. Even though the instability of TMTC3DD>AA prohibited us from comparing its 
ability to rescue the O-mannosylation of E-cadherin in HEK293SC/TMTC1,2,3,4 cells to WT 
TMTC3 and TMTC3EE>AA, we were able to show that TMTC3EE>AA rescues O-
glycosylation of E-cadherin as E-cadherin still binds Con A in TMTC3EE>AA transfected 
cells (Supplemental Fig. 3B, lane 8). This potentially links the TMTC3 Asp31Asp32 (DD) 
diacidic motif to its activity. In Xenopus, neither the TMTC3EE>AA nor TMTC3DD>AA 
construct was able to rescue the delay in gastrulation caused by the Tmtc3 morpholino 
(Fig. 6A and B). These results indicated that the diacidic residues in loop 1 were 
important for protein stability, possibly the transferase activity or complex formation.  
The glycosylation profile, combined with the trypsin protection of the C-terminal 
domains, placed the TPRs within the ER lumen for both TMTC3 and TMTC4. This is 
similar to the TPR regions of TMTC1 and TMTC2 (Sunryd et al., 2014). TMTC3 and 
TMTC4 encode eleven and eight TPR motifs, respectively, according to TPRPred 
(Karpenahalli et al., 2007). TPR domains are found in proteins across species and 
organelles and participate in a number of activities including protein translocation, 
folding, and post-translational modification (Graham et al., 2019). Furthermore, TPR-
containing proteins comprise the largest functional family within the cellular 
proteostasis/chaperome network (Brehme et al., 2014). TPRPred predicted that the 
eleven TPR motifs of TMTC3 are organized into clusters of three and eight, while 
TMTC4 has eight sequential TPRs. The differences in the organization of the TPR 
domains for TMTC3 and TMTC4 could have implications for their functions.  
Extensive bioinformatic analysis shows that long stretches of consecutive TPR 
domains (observed up to sixteen) tend to be more promiscuous in their selectivity 
(Magliery and Regan, 2005). Given that TMTC3 and TMTC4 both possess a stretch of 
eight consecutive motifs, this suggests that they may bind a number of substrates. This 
is most similar to the well-studied TPR-containing cytoplasmic O-GlcNAc transferase 
(OGT), which contains a stretch of 12.5 TPRs. The structure of OGT revealed that the 
TPRs form a super helix with conserved Asn along the concave surface that form a 
continuous ladder. The Asn in OGT that are particularly well-conserved are those at 
positions 6 and 9 in the TPR consensus and thought to contribute to inter-repeat 
interactions (Jínek et al., 2004). Seven of the eleven TPRs in TMTC3, as predicted by 
TPRPred, have Asn at position six and seven out of eight of the TPRs in TMTC4 have 
Asn at position six in addition to two of the eight having Asn at position nine. The 
number of conserved Asn at positions six and nine of the predicted TPRs in TMTC3 and 
TMTC4 suggests that they may form super helical structures and use the Asn to 
nucleate protein-protein interactions as this also mimics the Asn conservation observed 
in the ARM-repeat proteins importin- and -catenin, which contribute to the binding of 
the target peptide (Conti et al., 1998; Huber and Weis, 2001). -catenin was shown to 
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interact with E-cadherin through conserved Asn on its ARM-repeat domains. -catenin 
has twelve ARM-repeat domains and five of the domains contain an Asn at position 13 
and are responsible for recognizing the backbone of extended peptides. Furthermore, 
alignment of murine cadherin family sequences (M-cadherin, OB-cadherin, desmocollin 
1a and desmoglein 1) to E-cadherin show that many of the observed E-cadherin/-
catenin interactions are likely to be conserved among other cadherin family members. 
TMTC3 contains seven Asn at a conserved position on its TPR motifs, which could be 
used to interact with the well conserved family of cadherins in order to recruit the 
substrates for O-mannosylation near the ER membrane. 
Analysis of TPR-containing protein structures and their ligands revealed that 
smaller clusters of three and four TPRs corresponds to co-chaperone function (Brehme 
et al., 2014; Graham et al., 2019). Like one of the most well-studied TPR structures in 
the protein HoP, the N-terminal cluster of three TPRs in TMTC3 may bind and recruit 
chaperones for protein homeostasis, analogous to the MIR domains in the POMT/Pmts 
(Scheufler et al., 2000; Fujimori et al., 2017). MIR domains are observed in six non-
redundant proteins, all of which target to the ER (Nielsen, 2017; Letunic and Bork, 
2018). Stromal cell-derived factor 2 (SDF2) is a small protein of 211 amino acids 
comprised primarily of three MIR domains. While not much is known about MIR domain 
function for SDF2 and its isoform, SDF2L1, their MIR domains have been found to 
regulate the chaperone cycle of BiP (Fujimori et al., 2017). Both proteins form a stable 
complex with the ER J-domain protein ERdj3 and inhibit the aggregation of misfolded 
ER cargo by binding non-native proteins and promoting the BiP-substrate interaction 
cycle. We hypothesize that the three TPR motif cluster of TMTC3 may form a similar 
complex with chaperones for the delivery of unfolded substrate in order to expose 
putative sites for O-mannosylation. 
Thirty-seven members of the cadherin superfamily of cell membrane receptors 
were identified as major carriers of O-mannose glycans (Vester-Christensen et al., 
2013). Cell-surface receptors of the cadherin family mediate cell-cell adhesion at sites 
of cell-cell contact, which is crucial for cells to function in an integrated manner (Lodish 
et al., 2000; Meng and Takeichi, 2009). In our study, cells lacking TMTC1-4 stained for 
cadherins display cell-cell attachment irregularity appearing less round and consistent in 
shape (Fig. 4A). In combination with the data demonstrating that TMTC3 is involved in 
the O-mannylation of E-cadherin, this suggests that TMTC3 plays a role in cellular 
adherence through the O-mannosylation of E-cadherin. 
Cadherins contain multiple repeats of extracellular cadherin (EC) domains and 
they mediate cell-cell adhesion by trans homodimerization between the most distal EC1 
and EC1-2 domains on apposed cells (Cavallaro and Christofori, 2004; Yagi, 2008; 
Brasch et al., 2012). The other EC domains play a critical role in presenting the EC1 
and 2 domains so that they may form these homodimers. The O-mannose modified 
sites identified are confined to the EC2-5 domains of both classic type 1 and 2 
cadherins and these sites also appear to be evolutionarily conserved. E-cadherin, a 
type I classical cadherin, holds epithelial sheets together and is highly abundant at the 
sites of cell-cell contact along lateral surfaces (Lodish et al., 2000). We found that 
HEK293SC/TMTC1,2,3,4 cells adhere less to the immobilized extracellular region of E-
cadherin than HEK293SC and HEK293SC/POMT1,2 cells suggesting that genetic 
manipulation of the TMTCs affects E-cadherin’s ability to homodimerize (Fig. 4D and E). 
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Complementation of HEK293SC/TMTC1,2,3,4 cells with TMTC3 increased E-cadherin 
mediated cell-cell adhesion, therefore demonstrating that TMTC3 O-mannosylation of 
E-cadherin plays a crucial role in its ability to homodimerize (Fig. 4D and E, and Fig. 3). 
Given that E-cadherin is also crucial during embryogenesis, the effects we observe 
upon knockdown of Tmtc3 and subsequent rescue of the gastrulation delay with human 
TMTC3 WT, could be attributed to the role TMTC3 plays in E-cadherin mediated cell-
cell adhesion and O-mannosylation (Fig. 6)(Halbleib and Nelson, 2006).  
Mutations in TMTC3 were identified in patients with Cobblestone lissencephaly 
and PVNH, common brain malformations caused by defects in neuronal migration 
(Jerber et al., 2016; Farhan et al., 2017). More specifically, three of the mutations 
(R488Efs, F562Lfs and G384E variants) identified in Cobblestone lissencephaly 
patients that possess a significant number of clinically observed neurological defects 
were found to be unstable in our protein degradation assay (Jerber et al., 2016)(Fig. 5). 
The rapid degradation of these variants could explain the development delays observed 
in patients due to lack of TMTC3. Our Xenopus developmental studies revealed that two 
of the mutants (H67D and R71H) lead to a developmental delay even though they were 
more stable in cells. Our characterization of the disease variants of TMTC3 provides a 
link between a previously uncharacterized protein and disease resulting from its 
mutation. 
TMTC1-4 are not only implicated in the O-mannosylation of cadherins but were 
also found to be involved in the O-mannosylation of several ER/Golgi resident proteins, 
including ERp57, ERdj4 and FKBP10 (Larsen et al., 2017a). Each of these are 
important chaperones for protein folding of the secretory pathway aiding in disulfide 
bond formation, BiP activation and proline cis trans isomerization. O-mannosylation of 
both trafficked and resident secretory pathway proteins could contribute to their quality 
control either through increasing favorable folding or enhancing degradation of specific 
substrates upon misfolding. While previous studies show that O-mannosylation is an 
important structural modification, recent studies show that it may also play a role in ER 
quality control (ERQC) (Xu and Ng, 2015). If certain mutants are stabilized, they could 
cause dysregulation of protein homeostasis due to an excess of O-mannose 
modification of particular ER resident chaperones.  
In conclusion, we demonstrate that TMTC3 is crucial for O-glycosylation of E-
cadherin and cell-cell adhesion and embryonic development. Evidence shows that 
although the TMTCs share architectural similarity, they perform distinct functions and 
help to regulate cellular homeostasis by participating in essential processes, post-
translational modification and calcium regulation. Altogether, TMTC3 is likely an enzyme 
mediating O-mannosylation, and we have shown that TMTC3 directed O-mannosylation 
is biologically important, however further studies are needed to better understand 
TMTC3’s direct activity as an O-mannosyltransferase and whether it requires other 
proteins for its activity, its function within the cell and how mutations in this gene cause 
disease. 
 
Experimental Procedures 
 
Plasmids and reagents: Dulbecco's modified Eagle's medium (DMEM), DMEM 
GlutaMax, fetal bovine serum, penicillin and streptomycin were purchased from 
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Invitrogen/ThermoFisher Scientific. Easy-Tag [35S]-Cys/Met was purchased from 
PerkinElmer Life Sciences. S-protein-agarose beads and S-tag antibody were 
purchased from EMD Millipore. Endo H, PNGase F, Protoscript II first strand cDNA 
synthesis kit and all cloning reagents were purchased from New England Biolabs. 
FastStart SYBR Green qPCR mix was purchased from Roche Diagnostics, and all 
primers were acquired from IDT DNA. IRDye® 800CW Goat anti-Mouse IgG and 
IRDye® 680RD Goat anti-Rabbit IgG were purchased from Li-COR Biosciences. Protein 
A sepharose CL-4B was purchased from GE Healthcare. Antibodies directed toward the 
following antigens were also purchased: calnexin (Enzo Life Sciences); calreticulin 
(ThermoFisher Scientific); E-cadherin (GeneTex); pan-cadherin (Sigma); ERp57 (gift 
from Dr. Taku Tamura, Akita University, Japan), GM130 (BD Biosciences) and KDEL 
(Enzo Life Sciences). TMTC3 and TMTC4 cDNA was created by isolating RNA 
(HEK293T cells) and cloned into pcDNA3.1 A−, a plasmid harboring a C-terminal S-tag, 
using standard molecular biology techniques. All other chemicals were obtained from 
Sigma. 
 
Cell lines/Tissue Culture: HEK293T, 293A or COS7 cells were grown in DMEM 
supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/ml 
streptomycin. HEK293 cell lines (HEK293SC, HEK293SC/POMT1,2, and 
HEK293SC/TMTC1,2,3,4) were generously contributed by Dr. Henrik Clausen (University of 
Copenhagen) and grown in DMEM GlutaMax supplemented with 10% fetal bovine 
serum. 
 
In silico analysis of TMTC3 and TMTC4. The primary amino acid sequences of 
TMTC3 and TMTC4 were analyzed by UniProtKB and TPRpred to identify the number 
and position of putative TPR domains (Xu and Ng, 2015)(Karpenahalli et al., 2007; 
UniProt: a worldwide hub of protein knowledge, 2019). Hydrophobic domains were 
identified by the ΔG software, which predicts transmembrane domains (Hessa et al., 
2007). Putative N-linked glycosylation sites were identified by NetNGlyc (Gupta, 2002).  
 
Affinity Purification and glycosylation assay 
Transfected cells were lysed in MNT buffer (0.5% Triton X-100, 20 mM MES, 100 mM 
NaCl, 30 mM Tris-HCl [pH 7.5]). All steps were conducted at 4 C. The post-nuclear 
supernatant (PNS) was isolated by centrifugation followed by pre-clearing with un-
conjugated agarose beads for 1 hr. Cleared supernatant was incubated with S-protein 
agarose beads overnight and subsequently washed twice with wash buffer (0.05% 
Triton-X-100, 0.1% SDS, 300 mM NaCl, 100 mM Tris-HCl [pH 8.6]). After the final wash, 
glycosylation assays were performed by adding appropriate buffers and either mock, 
Endo H or PNGase F enzymes according to the manufacturer’s protocol. Finally, 
reducing sample buffer was added to all samples and they were analyzed by SDS-
PAGE. 
 
Confocal Microscopy 
Cells were fixed with 3.7% paraformaldehyde in phosphate buffered saline (PBS) for 15 
min followed by permeabilization with 0.1% triton X-100 for 15 min at 25 C. Slides were 
stained with the indicated primary antibodies followed by staining with appropriate Alexa 
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Fluor 488 or 594 secondary antibodies in immunostaining buffer (10% fetal bovine 
serum in 1X PBS). Slides were rinsed and mounted onto cover slips with VectaShield 
(Vector Laboratories). Images were obtained with a Fluoview 1000 MPE, 1X81 
motorized inverted research microscope (Olympus Inc.) equipped with a Hamamatsu 
C8484-05G camera. All images were acquired with a Plan Apo N 60x 1.42NA lens and 
processed by using the FV10-ASW and Adobe Photoshop software. For pan-cadherin 
staining, 24-well glass bottomed plates were prepared with 0.1% gelatin in PBS for 1 hr 
at 37 C prior to coating each well with 10 g/mL fibronectin (Sigma) overnight at 4 C. 
Cells were allowed to adhere in the wells for 2 hr at 37 C and subsequently fixed in 
methanol for 10 min at -20 C. Cells were stained with the indicated primary antibodies 
followed by staining with appropriate Alexa Fluor 488 or 594 secondary antibodies in 1X 
PBS containing 0.1% Tween, 2% bovine serum albumin (Fisher) and 0.02% sodium 
azide. Cells were rinsed and then incubated with Hoescht (Abcam) for 1 hr at 25 C. 
Images were obtained with a A1R: Nikon A1 resonant scanning confocal with TIRF 
module microscope equipped with an Andor Xyla camera. All images were acquired 
with a Plan Apo IR 60x 1.27WI lens and processed by using the Nikon Elements and 
Adobe Photoshop software. 
 
Alkaline extraction. Alkaline extraction was performed as previously described (Sunryd 
et al., 2014). Briefly, radiolabeled cells were resuspended in ice-cold homogenization 
buffer (20 mM HEPES, 5 mM KCl, 120 mM NaCl, 1 mM EDTA, and 0.3 M sucrose [pH 
7.5]) and passed through a 25-gauge needle 20 times. All subsequent steps were 
conducted at 4 C. The homogenate was centrifuged at 1,000 g for 10 min to pellet the 
nuclear fraction. The remaining PNS was centrifuged at 45,000 rpm in Beckman rotor 
(TLA 120.2) for 10 min to separate the cytosol (supernatant) from the cellular 
membranes (pellet). The cellular membrane fraction was resuspended in 
homogenization buffer, and a portion of the resuspended membranes was incubated 
with 0.1 M Na2CO3 (pH 11.5) for 30 min on ice. The alkaline extracted portion was 
centrifuged at 65,000 rpm for 20 min through a sucrose cushion (50 mM 
triethanolamine, 0.3 M sucrose [pH 7.5]) to separate soluble proteins from membrane 
proteins in the supernatant and pellet, respectively. The pH was adjusted in the alkaline 
extracted sample with 1 M Tris-HCl (pH 7.5). An excess of MNT was added to all 
fractions, and immunoprecipitation or affinity precipitation was performed with protein-A 
sepharose and appropriate antisera or with S-protein agarose, respectively.  
 
Trypsin protection: Transfected cells were resuspended in cold homogenization buffer 
(10 mM HEPES [pH 7.4], 10 mM KCl, 1.5 mM MgCl, 5 mM sodium EDTA, 5 mM sodium 
EGTA and 0.25 M sucrose) and passed through a 25-gauge needle 20-times.  All 
subsequent steps were conducted at 4 C. The homogenate was centrifuged at 1,000g 
for 10 min to pellet the nuclear fraction. The remaining PNS was centrifuged at 45,000 
rpm in Beckman rotor (TLA 120.2) for 10 min to separate the cytosol (supernatant) from 
the cellular membranes (microsomes). The microsomes were resuspended in 
homogenization buffer containing 0.1 M NaCl and 10 g trypsin and/or triton X-100 was 
added to a final concentration of 0.1%. After incubation at 27 C for 15 min, the reaction 
was quenched with 100 g soybean trypsin inhibitor. Reducing sample buffer was 
added and analyzed via SDS-PAGE. 
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Immunoblotting, endoglycosidase and affinity purification. Non-transfected and 
transfected cells were lysed in MNT and the PNS was isolated by centrifugation 
followed by total protein concentration determination using 595 nm Protein Assay Dye 
Reagent (Bio-Rad). All subsequent steps were conducted at 4 C. Equal amounts of 
total protein were split into three fractions. Preclearing was performed on one of the 
fractions with control agarose beads for 1 hr prior to affinity purification with S-protein 
agarose beads overnight. The remaining two fractions were subjected to a glycosylation 
assay by adding appropriate buffers and either mock or PNGase F enzyme according to 
the manufacturer’s protocol. Following endoglycosidase treatment, affinity purification 
for glycoproteins using Con A (Sigma) was performed overnight. Beads were washed 
twice in wash buffer. Finally, reducing sample buffer was added to all samples and they 
were analyzed by SDS-PAGE. Proteins were transferred to a polyvinylidene difluoride 
membrane and immunoblotted with the appropriate antisera. Blots were developed and 
TIFF files were acquired using a LI-COR Odyssey CLx Imager. Densitometric 
quantification of western blots was performed using ImageJ software (Fiji). The amount 
of E-cadherin bound to Con A was calculated by dividing the amount of E-cadherin in 
the PNGaseF treated transfected cells with the amount of E-cadherin in the PNGaseF 
treated non-transfected cells (mock). The amount of E-cadherin in non-transfected cells 
was set to 100%. Error bars represent the standard deviation for three independent 
experiments. TMTC3 S-tag transfected samples were also subjected to a glycosylation 
and carbohydrate binding assay that included both PNGaseF and 1-2,3,6 
mannosidase treatment. Briefly, transfected cells were lysed as described above and 
split into three fractions. Glycosylation assays were performed by adding appropriate 
buffers and either mock or PNGase F enzymes according to the manufacturer’s protocol 
and subsequent treatment with 1-2,3,6 mannosidase enzyme and appropriate buffers 
for 24 hr. Samples were analyzed as described above and the amount of E-cadherin 
bound to Con A was calculated by dividing the amount of E-cadherin in PNGaseF/1-
2,3,6-mannosidase treated samples by the amount of PNGaseF treated E-cadherin, 
which was set to 100%. Error bars represent the standard deviation for three 
independent experiments. 
 
qRT-PCR 
HEK293A cells were treated with regular growth media or dithiothreitol (2 mM) for 2 hr 
or tunicamycin (1 g/mL), thapsigargin (3 M), brefeldin A (2.5 g/mL) and MG132 (2.5 
M) for 24 hr prior to RNA isolation with RNAeasy Mini Kit (Qiagen). One g of purified 
RNA was reverse transcribed into cDNA using the Protoscript II Reverse Transcriptase 
kit (New England Biolabs). Quantitative real time polymerase chain reactions (qRT-
PCR) were performed in 20 L reactions using the FastStart universal SYBR Green 
master (Rox) kit (Roche diagnostics Corp.) on an Mx3000P real-time PCR machine 
(Agilent Technologies Inc.) according to manufacturer’s instructions. Changes in mRNA 
levels were calculated using the change in cycle threshold value method with -actin as 
the reference gene (Pfaffl, 2001). Statistical analysis of the data was calculated using 
GraphPad Prism 5.0 (GraphPad software) and significance between treatment groups 
was determined using unpaired T-tests.  
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 The following primers were used: -actin (5’ GCACTCTTCCAGCCTTCC 3’, 5’ 
TGTCCACGTCACACTTCATG 3’), TMTC1 (5’ GCTGTTTCTATTGGCCTTTCTC 
 3’, 5’ TGTCTCTTTCACCAGCATCG 3’), TMTC2 (5’ GATGTCTTTGTCTTTCACAGGC 
3’, 5’ TGTTTCCCATCCAGTATAACCG 3’) TMTC3 (5’ TTTTCCTAAGCCATCCCCTG’, 
5’ ACAAAACCACAAAAGAGGCTG 3’), TMTC4 (5’ CCCTCATTAAGTCCATCAGCG 3’, 
5’ ATAACGAGAAATCCCAGGCC 3’), POMT1 (5’ GTGAACTACCTCCCGTTCTTC 3’, 5’ 
CACAGGGAGCAGAAGGATTT 3’), POMT2 (5’ GGCACTGGCCTATCAACTATC 3’, 5’ 
CAACAGATTCAGCCACCAAAC 3’) and BiP (5’ CTGCCATGGTTCTCACTAAAATG 3’, 
5’ TTAGGCCAGCAATAGTTCCAG 3’). 
 
Cycloheximide chase analysis. HEK293T cells were transfected with S-tagged WT 
TMTC3 or mutant TMTC3 for 40 hr prior to incubation with 100 µg/mL of cycloheximide 
for indicated times. Cell lysates were prepared and the expression of S-tag TMTC3 was 
analyzed by Western blots. Briefly, transfected cells were lysed in MNT. Protein 
concentration of cell lysates was determined by using the 595 nm Protein Assay Dye 
Reagent (Bio-Rad). Western blots were carried out after 9% SDS-PAGE. After 
incubation with IRDye-conjugated secondary antibodies, the protein-antibody 
complexes were visualized by the LI-COR Odyssey CLx Imager and densitometric 
quantification of western blots was performed using ImageJ software (Fiji). The stability 
of TMTC3 was calculated by dividing the amount of TMTC3 WT or mutants in 
cyclohexmide treated samples (2-24 hr time points) by the amount of TMTC3 in 
untreated samples (0 time point), which was set to 100%. Error bars represent the 
standard error for three independent experiments. 
 
Cell Adhesion Assays. Substrates included bovine fibronectin (Sigma), E-cadherin 
(R&D Systems) and BSA (Fisher). Falcon Probind 96-well plates were coated with 25 
and 50 μg/ml substrates in PBS overnight at 4 °C, rinsed with PBS, and blocked with 10 
mg/ml BSA in PBS for 2 hr at 25 C. Cells were harvested in serum free media by 
resuspension. 60,000 cells/well were seeded and the adhesion assay was performed 
for 1 hr at 37 °C in 5% CO2 in a humidified atmosphere. Non-adherent cells were 
washed away with serum free media. Adherent cells were fixed for 20 min with 4% 
formaldehyde in PBS, rinsed with PBS, and permeabilized with 0.1% triton X-100 for 20 
min prior to staining with Hoescht (Abcam). Excess stain was removed with PBS. Each 
assay point was derived from three independent experiments. 
 
Xenopus embryo handling and media. Eggs were obtained from adult Xenopus 
laevis, fertilized, and cultured as described previously (Cousin et al., 2008). Embryos 
were staged according to (Nieuwkoop and Faber 1994). Briefly, after in vitro fertilization, 
the eggs were dejellied in 2% cysteine (pH ~8.3) and then cultured in 3% Ficoll in 
Modified Barth’s Solution (1X MBS) at 15 °C until they reached the desired stage for 
injection. Embryos were grown in 0.1X MBS at either 15 or 18º C. Time-lapse video 
microscopy was performed at 18º C. 
 
Microinjection experiments. Morpholinos (GeneTools, LLC) for Tmtc1, 2, 3 and 4 
were designed to block translation of the respective proteins and contain a 3’-
fluorescein modification by the manufacturer and injected (10 ng) at the one-cell stage. 
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mRNAs of human TMTC3 WT and previously described mutants, cloned into pcDNA3.1 
A− with a C-terminal S-tag, were transcribed using T7 polymerase following linearization 
of plasmids with EagI or DraIII. Transcripts were desalted on G-50 Nick columns 
(Pharmacia), extracted with phenol/chloroform, and ethanol precipitated. Transcripts 
were quantified by absorbance at 260 nm and resuspended at 0.2 g/ml in DEPC-
treated H2O. Transcripts (1 ng total) were injected at the one-cell stage, following 
injection of the TMTC3 morpholino. 
 
Embryo and cell imaging. Pictures of embryos were taken using the Zeiss Axiovert 
200 M inverted microscope equipped with a Ludl xyz-stage control and a Hamamatsu 
Orca camera (Fig. 6) or BZ-X Analyzer equipped with Nikon 10X CFI PlanFluor lens and 
BZX710 camera (Keyence). Images were taken using either the AxioVision software 
(Zeiss) (Fig. 6) or the BZ-X capture software (BZ-X700 Analyzer)(Fig. 6). The diameter 
of the blastopore was measured using ImageJ software (Fiji) and quantified using 
GraphPad Prism 5.0 (GraphPad software). Statistical analysis between morpholino and 
TMTC3 construct injected groups was performed using one-way ANOVA and *, **, *** 
indicates a P-value of less than 0.05, 0.01 and 0.001, respectively. Error bars represent 
standard deviation. 
 
Protein extraction and analysis. Embryonic proteins were extracted from 10-20 frozen 
embryos using 1X MBS (Laskey et al., 1977) containing 1% triton X-100, protease 
inhibitor cocktail (Sigma), 2 mM phenylmethylsulfonid fluoride, and 1 mM EDTA on ice 
followed by 16,000 g centrifugation for 30 min at 4 C. Supernatant was either directly 
added to an equal volume of 2X Laemmli buffer containing 2% -mercaptoethanol or 
precipitated with trichloroacetic acid (Sigma) and washed with acetone prior to 
resuspension in 2X Laemmli containing 2% of -mercaptoethanol. Western blots were 
performed using standard techniques and the presence of translated TMTC3 constructs 
was assessed using anti-S-tag antisera. 
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Figure Legends 
 
Figure 1. TMTC3 and TMTC4 are ER resident proteins. (A) The organization of 
TMTC3 and TMTC4 with signal sequences (black), hydrophobic domains (teal) and 
TPR domains (orange) as designated. The start and end positions of each domain are 
as follows: TMTC3 hydrophobic domains (aa 9-30, 94-115, 140-161, 169-187, 192-214, 
235-257, 321-340, 347-367, 371-393 and 402-422), TMTC3 TPR motifs (aa 412-445, 
446-479, 480-513, 529-562, 563-596, 597-630, 632-665, 669-702, 703-736, 738-771 
and 772-805), TMTC4 hydrophobic domains (aa 20-38, 109-130, 142-161, 170-192, 
203-221, 225-245, 269-291, 320-339, 353-374, 381-403, 412-433 and 440-460) and 
TMTC4 TPR motifs (aa 448-481, 482-515, 516-549, 550-583, 584-617, 618-651, 652-
685 and 686-719). Predicted endogenous N-linked glycosylation sites are indicated by 
small black, branched structures. (B) HEK293T cells were transfected with S-tagged 
TMTC3 or TMTC4 as indicated and were affinity purified from the cell lysate and media 
using S-protein agarose. Samples were then subjected to a glycosylation assay with 
either EndoH (lanes 2, 5, 8, 11, 14 and 17) or PNGaseF (lanes 3, 6, 9, 12, 15 and 18) 
digestion as indicated. Reducing sample buffer was added and the samples were 
analyzed by a 6% (TMTC3 S-tag) and 8% (TMTC4 S-tag) SDS-PAGE. (C) Cellular 
localization of TMTC3 and TMTC4 was investigated by confocal microscopy. COS7 
cells were transfected with TMTC3 or TMTC4 cDNA. Fixed cells were stained with S-
tag, ERp57 (ER) or GM130 (Golgi) antisera. Nuclei were visualized by DAPI staining 
(blue). Scale bars correspond to 10 µm. 
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Figure 2. TMTC3 and TMTC4 are transmembrane proteins with their TPR domains 
facing the ER lumen. (A) HEK293T cells were transfected with S-tagged TMTC3 or 
TMTC4 as indicated and radiolabeled for 1 hr with [35S]-Cys/Met. Cells were 
homogenized and fractionated prior to alkaline extraction. The fractions collected were 
whole cell lysate (WCL), nucleus (N), cytosol (C), total membrane (TM), as well as 
supernatant (S) and pellet (P) fractions upon alkaline extraction of the TM. All samples 
were subjected to affinity purification with S-tag agarose or calnexin (CNX) and 
calreticulin (CRT) immunoprecipitation where indicated. Samples were analyzed via 
SDS-PAGE and detected via autoradiography. (B) TMTC3 S-tag and TMTC4 S-tag 
were expressed in HEK293T cells. Cells were homogenized and microsomes were 
isolated by ultracentrifugation then resuspended in homogenization buffer. Aliquots of 
the ER microsomes were incubated for 15 min at 27 ˚C with or without triton X-100 and 
trypsin where indicated. Samples were separated on 9% SDS-PAGE and 
immunoblotted for the S-tag epitope. (C) Putative trypsin protease cleavage areas 
(dashed line) on TMTC3 and TMTC4 based on exposed potential cleavage residues 
and size of cleaved bands in B. Orange hexagons represent ER lumen facing TPR 
motifs. 
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Figure 3. TMTC3 rescues O-mannosylation of E-cadherin in HEK293SC/TMTC1,2,3,4 
cells. (A) HEK293T cells expressing TMTC1, 2, 3 or 4 were harvested in isotonic buffer 
and homogenized. A portion of the cell homogenate was subjected to ultracentrifugation 
and resuspended in reducing sample buffer. This was considered the total membrane 
fraction (lanes 1-5). An excess of MNT lysis buffer was added to an equal amount of cell 
homogenate and subjected to S-protein agarose affinity purification (lanes 6-10). 
Proteins were detected by immunoblotting with appropriate antisera directed against the 
S-tag epitope and SERCA2B. (B) S-tagged TMTC1, 2, 3 or 4 cDNA was transfected into 
indicated cell lines. Cell lysates were collected and split, one half subjected to treatment 
with endoglycosidase PNGaseF (lanes 2, 4, 6, 8 and 10), prior to pulling down 
glycosylated proteins with concanavalin A (Con A). Samples were then analyzed by 6% 
SDS-PAGE and immunoblotted with E-cadherin antisera to assess levels of 
glycosylated E-cadherin. (C) Quantification of relative density of O-glycosylated E-
cadherin from HEK293SC/TMTC1,2,3,4 cells transfected with TMTC1, 2, 3, and 4 cDNA, 
respectively. Statistical significance between non-transfected cells and TMTC1, 2, 3 or 4 
transfected cells was calculated using one-way ANOVA. Measurements designated (**) 
have a P value of <0.01. Error bars represent standard deviation. (D) 
HEK293SC/TMTC1,2,3,4 cells were transfected with S-tagged TMTC3 cDNA. Cell lysates 
were collected and subjected to a glycosylation assay with either PNGaseF (lane 2) or 
combined PNGaseF and α1-2,3,6 mannosidase treatment (lane 3) prior to affinity 
purification of glycosylated proteins by Con A. Samples were then analyzed via 9% 
SDS-PAGE and immunoblotted with E-cadherin antisera. Error bars represent standard 
deviation. 
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Figure 4. TMTC3 enhances E-cadherin mediated cellular adherence. (A) Cellular 
localization of cadherins was investigated by confocal microscopy. HEK293SC, 
HEK293SC/POMT1,2 and HEK293SC/TMTC1,2,3,4 cells were fixed and stained with pan-
cadherin antisera. Scale bars correspond to 50 µm. (B) Adherence was assessed in 
previously described cell lines. Cells were resuspended in growth media and 1 x 106 
cells were subsequently plated in a 24-well plate. Cells were allowed to adhere for 30 
min. Unadhered cells were collected and adhered cells were trypsinized and collected. 
The data describes the % of floating (unadhered) cells over the total (unadhered + 
adhered) after counting both fractions. Statistical significance between cell types was 
calculated using one-way ANOVA. Measurements designated (**) have a P value of 
<0.01. Error bars represent the standard deviation. (C) TMTC1, 2, 3 or 4 cDNA was 
transfected into HEK293SC/TMTC1,2,3,4 cells and adherence was assessed as described in 
B. The increase or decrease of adherence of cells transfected with TMTC1, 2, 3 or 4 
was established by subtracting the % of mock transfected adhered cells (red dashed 
line) from the % of adhered, transfected cells (adhered/ (unadhered + adhered)). Error 
bars represent the standard deviation. Statistical significance between cell treatments 
was calculated using one-way ANOVA. Measurements designated *, ** or *** have a P 
value of <0.05, <0.01 or <0.001, respectively. (D) Cellular adherence to immobilized E-
cadherin was assessed via immunoassay. HEK293SC, HEK293SC/POMT1,2 and 
HEK293SC/TMTC1,2,3,4 cells and HEK293SC/TMTC1,2,3,4 cells transfected with TMTC3 were 
resuspended and 60,000 cells were placed on immobilized E-cadherin (50 µg/mL). Cells 
were allowed to attach for 1 hr prior to fixing with PFA, permeabilization with triton X-
100 and staining with Hoescht. Hoescht nuclear staining and DIC images (pictured) 
were acquired at 40X magnification. Scale bars correspond to 50 µm. (E) The number 
of cells adhered to E-cadherin in previously described cell lines was estimated by 
averaging 5 randomized images capturing nuclei intensity at 405 nm within each well 
from three independent experiments. Error bars represent the standard deviation. 
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Figure 5. TMTC3 WT and disease variant stability. (A) HEK293T cells were 
transfected with S-tagged TMTC3 WT or disease variant cDNA as indicated. Cells were 
treated with 100 μg/mL cycloheximide for the indicated time prior to collection, lysed in 
MNT and samples were subjected to affinity purification with S-protein agarose. 
Reducing sample buffer was added and samples were analyzed via 9% SDS-PAGE 
and immunoblotted for the S-tag epitope. Cell lysates were also subjected to 
precipitation with 10% trichloroacetic acid, analyzed via 9% SDS-PAGE and 
immunoblotted with KDEL antisera to determine stability of GRP94 and BiP (WCL). (B) 
Time points were collected at 0, 2, 4, 8, 16 and 24 hr after cycloheximide treatment. The 
amount of TMTC3 protein remaining at 2, 4, 8, 16 and 24 hr was quantified and 
normalized to the starting material (0 h) and averaged from three independent 
experiments. Error bars represent standard error of the mean. (C) HEK293T cells were 
transfected with S-tagged TMTC3 WT or the TMTC3 R488Efs disease variant as 
indicated. Cells transfected with the TMTC3 R488Efs variant were treated with 20 μM 
MG132 for 12 hr prior to collection and lysis in MNT (lane 4). Samples were subjected 
to affinity purification with S-protein agarose and analyzed via SDS-PAGE prior to 
immunoblotting for the S-tag epitope. 
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Figure 6. Knockdown of Tmtc3 in developing Xenopus laevis emrbyos affects 
gastrulation. (A) Embryos were injected with 10 ng of morpholinos against Tmtc1, 
Tmtc2, Tmtc3 and Tmtc4 at the one-cell stage. The embryos were scored for 
gastrulation when control embryos reached stage 11-12. Embryos were also injected 
with 10 ng of Tmtc3 morpholino and subsequently injected with S-tagged           
huTMTC3WT, huTMTC3DD>AA huTMTC3EE>AA, huTMTC3H67D, huTMTC3R71H and 
huTMTC3G384E at the one-cell stage. The embryos were scored as described above. (B) 
The average of three or more independent experiments is plotted on the graph. 
Statistical significance between injection conditions was calculated using one-way 
ANOVA. Measurements designated (***) have a P value of <0.001. The error bars 
represent the standard deviation to the mean. The number of embryos analyzed are as 
follows: non-injected n=75, TMTC1MO n=43, TMTC2MO n=45, TMTC3MO n=43, 
TMTC4MO n=40, TMTC3MO + huTMTC3 n=35, TMTC3MO + huTMTC3DD>AA n=33, 
TMTC3MO + huTMTC3EE>AA n=30, TMTC3MO + huTMTC3H67D =28, TMTC3 MO + 
huTMTC3R71H n= 22 and huTMTC3G384E n =33.   
 
